Inventor
LIN RONG-HWA
US20 patents
⚠️ This page may combine multiple inventors who share the name “LIN RONG-HWA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIN RONG-HWA
8 patentsUS8287871B2Oct 16, 2012
Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies
LIN RONG-HWA11 citations91
US8298540B2Oct 30, 2012
Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies
LIN RONG-HWA13 citations90
US8828397B2Sep 9, 2014
Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cell
LIN RONG-HWA5 citations82
US8663641B2Mar 4, 2014
Anti-PSGL-1 antibodies
LIN RONG-HWA6 citations82
US8557579B2Oct 15, 2013
Screening for modulators of PSGL-1 with respect to T cell or NK cell death
LIN RONG-HWA5 citations81
US9494574B2Nov 15, 2016
T-cell death-inducing epitopes
LIN RONG-HWA3 citations72
US8628775B2Jan 14, 2014
Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds
LIN RONG-HWA5 citations72
US9193794B2Nov 24, 2015
Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
LIN RONG-HWA1 citations50
BIOALLIANCE CV
4 patentsUS7674605B2Mar 9, 2010
Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
BIOALLIANCE CV40 citations90
US9950077B2Apr 24, 2018
Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof
BIOALLIANCE CV4 citations67
US10472422B2Nov 12, 2019
Tetravalent anti-PSGL-1 antibodies and uses thereof
BIOALLIANCE CV1 citations61
US9943610B2Apr 17, 2018
Hydrophilic self-immolative linkers and conjugates thereof
BIOALLIANCE CV1 citations61